Trial
NCT03617172
PROCLAIM -- Misoprostol in the Prevention of Recurrent CDI Prevent Recurrence of Clostridium Difficile Infection With Misoprostol
Phase IITERMINATEDOPERATIONALConfidence: HIGH
Sponsor
Vanderbilt University Medical Center
Collaborators
National Institutes of Health (NIH)
Condition
Clostridium Difficile
Intervention
Misoprostol 100Mcg Tab
Why stopped
Low enrollment
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2022-11-30